JORGE BENITO CANNATA ANDIA-rekin lankidetzan egindako argitalpenak (46)

2024

  1. Serum phosphate is associated with increased risk of bone fragility fractures in haemodialysis patients

    Nephrology Dialysis Transplantation, Vol. 39, Núm. 4, pp. 618-626

  2. Soluble Klotho, a Potential Biomarker of Chronic Kidney Disease–Mineral Bone Disorders Involved in Healthy Ageing: Lights and Shadows

    International Journal of Molecular Sciences, Vol. 25, Núm. 3

2022

  1. A single-oral bolus of 100,000 IU of cholecalciferol at hospital admission did not improve outcomes in the COVID-19 disease: the COVID-VIT-D-a randomised multicentre international clinical trial

    BMC medicine, Vol. 20, Núm. 1, pp. 83

  2. Executive summary clinical practice guideline of postmenopausal, glucocorticoid-induced, and male osteoporosis (2022 update)

    Revista de Osteoporosis y Metabolismo Mineral, Vol. 14, Núm. 1, pp. 5-12

2021

  1. Association of biochemical parameters of bone metabolism with progression and/or development of new aortic calcifications

    Revista de Osteoporosis y Metabolismo Mineral, Vol. 13, Núm. 1, pp. 10-16

2020

  1. Effect of frailty and sarcopenia on the risk of falls and oste oporotic fractures in anun selected population

    Revista de Osteoporosis y Metabolismo Mineral, Vol. 12, Núm. 3, pp. 81-86

  2. Impact of vascular calcification on bone health and mortality in kidney transplant patients

    Revista de Osteoporosis y Metabolismo Mineral, Vol. 12, Núm. 2, pp. 53-61

2015

  1. The hypercalcaemia of CYP24A1 inactivation: Newways to improve diagnosis and treatment

    Clinical Kidney Journal, Vol. 8, Núm. 4, pp. 456-458

2013

  1. Osteoporosis and adynamic bone in chronic kidney disease

    Journal of Nephrology, Vol. 26, Núm. 1, pp. 73-80

2011

  1. Bone: Osteoporosis therapy-Time to consider renal function

    Nature Reviews Endocrinology

2010

  1. Cuantificación del riesgo de fractura por fragilidad con la herramienta FRAX® en pacientes trasplantados renales

    Revista de la Sociedad Española de Enfermería Nefrológica, Vol. 13, Núm. 2, pp. 98-103

2009

  1. Vascular calcifications, vertebral fractures and mortality in haemodialysis patients

    Nephrology Dialysis Transplantation, Vol. 24, Núm. 1, pp. 239-246

2008

  1. Progression of vascular calcifications is associated with greater bone loss and increased bone fractures

    Osteoporosis International, Vol. 19, Núm. 8, pp. 1161-1166

  2. Tissue-specific effect of VDR gene polymorphisms on the response to calcitriol

    Journal of Nephrology, Vol. 21, Núm. 6, pp. 843-849

2007

  1. Los polimorfismos del gen del receptor de la vitamina D (VDR) modulan la respuesta a la vitamina D de forma tejido específica

    Revista Española de Enfermedades Metabólicas Oseas, Vol. 16, Núm. 1, pp. 20-27

  2. Los polimorfismos del gen del receptor de la vitamina D (VDR) modulan la respuesta a la vitamina D de forma tejido específica

    Revista Espanola de Enfermedades Metabolicas Oseas, Vol. 16, Núm. 1, pp. 20-27

2006

  1. Vitamin D supplementation: What is right?

    Clinical Cases in Mineral and Bone Metabolism

2005

  1. Postmenopausal women with Colles' fracture have bone mineral density values similar to those of controls when measured with calcaneus quantitative ultrasound

    European Journal of Internal Medicine, Vol. 16, Núm. 8, pp. 561-566

  2. Postmenopausal women with Colles' fracture have lower values of bone mineral density than controls as measured by quantitative ultrasound and densitometry

    Journal of Clinical Densitometry, Vol. 8, Núm. 4, pp. 430-435

2004

  1. Prevalencia e incidencia de osteoporosis en el varón. Capacidad de predecir fractura osteoporótica mediante la utilización de la densitometría

    Revista Espanola de Enfermedades Metabolicas Oseas, Vol. 13, Núm. 5, pp. 87-92